Control of API release with matrix polymorphism in tristearin microspheres

Amanda M Pluntze1, Jonathan L Cape2, Nathaniel D Klaus2

  • 1Global Research and Development, Small Molecules, Lonza, 64550 Research Road, Bend, OR 97703, United States.

Summary

Drug release from solid lipid matrices like tristearin depends on its polymorphic form. Understanding triglyceride polymorphism guides pharmaceutical formulation for controlled drug release rates.